Many rely on medications to deal with heartburn in a pinch. But using some of the more popular options may increase your dementia risk, according to research.

Braintree Laboratories, a part of Sebela Pharmaceuticals and a leading manufacturer of gastroenterology pharmaceutical products, announced positive topline results from two pivotal US phase 3 clinical ...

Sebela Pharmaceuticals announced that tegoprazan, a novel potassium-competitive acid blocker (P-CAB), achieved statistical superiority over the proton pump inhibitor lansoprazole in two pivotal Phase ...

Pharmacist Deborah Grayson has warned of 'rebound reflux', which happens when the medication makes the problem worse, making ...

Voquezna is a potassium-competitive acid blocker. Here’s how it treats gastroesophageal reflux disease (GERD) and esophagitis.

Lansoprazole is a generic prescription oral capsule that treats stomach ulcers and several other conditions. Learn about uses, dosage, warnings, and more.

Lansoprazole (Figure 1) is a gastric acid secretion reducer designed to minimize the symptoms of GERD, and an ideal example of an API that can be characterized via 1 H NMR spectroscopy.

Summary Lansoprazole and omeprazole are both PPIs approved by the FDA to treat several digestive conditions, including symptomatic GERD. They are both available as prescription medications and OTC.

And that was a non-inferiority endpoint. So vonoprazan 20 mg was non-inferior to lansoprazole 30 mg, each given once daily in healing erosive esophagitis after 8 weeks.

Vonoprazan exhibited comparable adverse event (AE) rates to lansoprazole in the trial. Common adverse events in the healing phase included gastritis, diarrhea, abdominal distension, abdominal pain ...

In addition, the drug "provided superior maintenance of healing in all grades of erosive esophagitis, compared to lansoprazole, a commonly prescribed PPI, and provided 24-hour heartburn relief on ...